Sartorius Stedim Biotech SA
PAR:DIM
Wall Street
Price Targets
DIM Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for DIM is 263.22 EUR with a low forecast of 202 EUR and a high forecast of 378 EUR.
Operating Income
Forecast
Operating Income Estimate
Sartorius Stedim Biotech SA
For the last 8 years the compound annual growth rate for Sartorius Stedim Biotech SA's operating income is 11%. The projected CAGR for the next 3 years is 29%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DIM's stock price target?
Price Target
263.22
EUR
According to Wall Street analysts, the average 1-year price target for DIM is 263.22 EUR with a low forecast of 202 EUR and a high forecast of 378 EUR.
What is Sartorius Stedim Biotech SA's Revenue forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Sartorius Stedim Biotech SA's revenue is 15%. The projected CAGR for the next 3 years is 12%.
What is Sartorius Stedim Biotech SA's Operating Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for Sartorius Stedim Biotech SA's operating income is 11%. The projected CAGR for the next 3 years is 29%.
What is Sartorius Stedim Biotech SA's Net Income forecast?
Projected CAGR
33%
For the last 8 years the compound annual growth rate for Sartorius Stedim Biotech SA's net income is 13%. The projected CAGR for the next 3 years is 33%.